Study skin microbiome in certain skin diseases
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at the bacteria (microbiome) living on the skin in people with specific skin conditions, and in healthy volunteers. The results may help researchers understand what skin microbes have to do with these diseases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 89 (not under 18 or over 90)
- You have one of these conditions: cutaneous T-cell lymphoma (IA–IIA or IIB+), or CD30+ related disorders, or plaque psoriasis (BSA > 5%), or moderate-to-severe atopic dermatitis on bleach-bath therapy
- If you’re a healthy volunteer, you should be similar in age and sex to the patient group
- You must be able and willing to give informed consent for the study and skin tissue/bank research
- You cannot be taking systemic antibiotics now, and you must not have had systemic antibiotics in the past 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a spray solution (APR-TD011®) for people with early-stage mycosis fungoides and looks at how the bacteria on the skin change before and after treatment. It may help researchers understand whether the spray improves the skin environment that can affect this lymphoma.
This study tests whether a special skin care body wash can improve skin lesions in people with mycosis fungoides, a type of skin lymphoma. Researchers will look at skin bacteria before and after using the wash.
This study collects blood, urine, and possibly small tissue samples to learn more about cutaneous T-cell lymphoma (CTCL) and either eczema or atopic dermatitis. It may help researchers better understand these skin conditions and improve future treatments.
This study looks at differences in the gut and skin microbiome (the germs living in and on the body) in people with vitiligo and in people without vitiligo. It aims to understand what might be linked to how vitiligo spreads over time.
This study looks at why skin lymphomas behave differently from person to person and may identify new targets for treatment. You may be invited if you have (or are being evaluated for) a suspected or confirmed skin lymphoma.
This study collects stored tissue samples (from skin or other needed procedures) from people with CTCL, Sézary syndrome, or lymphomatoid papulosis, especially when you are starting or changing treatment. It’s meant to help researchers learn more about these illnesses and may support future research.
Hear when a new Cutaneous T Cell Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.